Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
about
Drug-induced diabetes mellitusComplexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesManagement of diabetes mellitus type-2 in the geriatric population: Current perspectivesDiabetes in African AmericansFactors associated with results and conclusions of trials of thiazolidinedionesThe management of type 2 diabetic patients with hypoglycaemic agentsOptimal therapy of type 2 diabetes: a controversial challengeQuantitative assessment of the bidirectional relationships between diabetes and depression.Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA.Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys.Diabetes diagnosis and exercise initiation among older Americans.Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes.Emerging treatment options for type 2 diabetesCarotid body, insulin, and metabolic diseases: unraveling the links.Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemiaAlbumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulinThe comorbidity of diabetes mellitus and depressionBariatric surgery for type 2 diabetes: weighing the impact for obese patients.Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines.Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission.Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registryPeptide modulators of alpha-glucosidase.Inhaled human insulin (Exubera): clinical profile and patient considerations.Influence of gastrectomy for stomach cancer on type 2 diabetes mellitus for patients with a body mass index less than 30 kg/m(2).Geographic variation in pharmacotherapy decisions for U.S. Medicare enrollees with diabetes.Quality of life and patient-perceived difficulties in the treatment of type 2 diabetesEffect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivityEmerging drugs for diabetic nephropathy.The insulin response integrates increased TGF-β signaling through Akt-induced enhancement of cell surface delivery of TGF-β receptors.Dispelling myths and removing barriers about insulin in type 2 diabetes.Recent findings concerning thiazolidinediones in the treatment of diabetes.Antihypertensive medications and blood sugar: theories and implications.Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes RegistryAdjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.Exercise-like effects by Estrogen-related receptor-gamma in muscle do not prevent insulin resistance in db/db mice.
P2860
Q22306015-7C8A34CD-A06F-49A6-AE9F-949AEA074B5DQ24289423-B6542991-654B-4FEB-B745-0F88B9343E41Q24642503-4B53EC21-61F1-427B-80D5-C12A5AB1A4F3Q26999670-F1CA1593-7BAF-400A-9EFE-16A96D7D6753Q28394087-1CF1C658-E0B3-4CE5-B317-E7EBA309469AQ28475588-5698280E-2165-4314-AF30-1ADDDD7AEE2AQ30417363-D49E69A3-F202-4E54-B372-95CBE4DE34D3Q33577712-56E26115-31CD-4A04-90C4-AF4B6D45A6E5Q33618693-AF99CFEF-0EB0-4F6C-86B6-D118CF405B75Q33700904-FCCF6508-9136-4CE3-86E0-00F282DE7F3FQ33838353-F844FC8F-6DBC-4757-AC1E-0F41ADEE43BAQ33929438-8F312EF3-A86F-4B5E-927B-C66E655C4CA0Q34040213-62E09B68-F490-4002-AC94-3AE0BA4DB7F5Q34381281-C2757731-304E-49CD-B03C-E6955B9033FEQ34419319-BCB9ADB1-9C19-4BF0-93B1-D03592DD1359Q34558840-3BD3E1B0-FDF4-4CD3-8058-AC52BA34428AQ34569271-C2C14EE5-C167-4359-A3CA-5470AD3F6641Q34613075-12E0CB37-CBA6-4F77-93C9-88DC46786DBFQ34620604-F915053B-0FE4-4591-9E31-7F4D4B0D6752Q34866766-F91EE000-F684-4A23-9463-52240C600882Q35008794-1D9DD8C0-3273-4585-BCE7-07493BCF3275Q35073384-88365A35-EDDB-4672-A127-11B885575559Q35123342-2ECDAB6F-CED9-4EC1-9C1C-468F5D88B7C6Q35183113-5CFFD652-B46E-41F6-8825-3E07D4F91BB2Q35834348-EBBDDE01-D9E9-4794-9C52-55CAB03F2B71Q36013146-D84A5774-7829-4D6C-9A83-A8A3183D8B37Q36028076-D0BB348E-EF38-442D-8BCD-D7F993F60AA5Q36098838-45D4F0C8-6453-45F8-964C-77CE55D147FDQ36250624-B737A864-4A96-4944-BAEB-38BC96EC85F8Q36264614-93E9713E-5CCB-4E89-962F-2236ACDB5E32Q36302838-246D8A5D-A494-465D-910B-860EFB76C000Q36347687-0F0C9793-30F6-4F67-8439-34677A99C948Q36378626-0941389C-9E1E-49AF-8C5D-37AA7B918190Q36407304-87F3EB26-9E18-464E-8025-765DC2342BFAQ36415349-124C35EA-943E-4137-94D6-F816AEC5595DQ36570720-3E46BF42-738C-42A9-A2B0-77BDE5CDD3F9Q36634230-2D035B5A-89B9-4C08-B152-C867307F5915Q36856384-A8E73BF1-5182-44A3-B5D2-C34379DC2ECCQ36906173-23CC6D3B-5641-4AC5-8F4C-4EEDAB5D2020Q36933850-D252FEFF-36CA-4BF0-8FDC-ECEC19FC7BEB
P2860
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@ast
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@en
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@nl
type
label
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@ast
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@en
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@nl
prefLabel
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@ast
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@en
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@nl
P356
P1476
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
@en
P2093
David M Nathan
P304
P356
10.1056/NEJMCP021106
P407
P577
2002-10-01T00:00:00Z